AIMEE BERT-MORENO: Open Payments
NPI 1215518345 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 28 payments from 5 companies in 2025. Trend: 2023 $1,158 · 2024 $1,215 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $520 |
| Lilly USA, LLC | 8 | $218 |
| Dexcom, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Wegovy, Ozempic, ZEPBOUND, MOUNJARO, Rybelsus, Dexcom G6 Transmitter, JARDIANCE, LEQVIO.
Industry payments across FL — which companies pay providers there.
